Oestrogen signalling inhibits invasive phenotype by repressing RelB and its target BCL2

A Gene-Expression Signature as a Predictor of Survival in Breast Cancer

van de Vijver, M. J., He, Y. D., Veer, L. V. ‘., Dai, H. A., Hart, A. A. M., Voskuil, D. W., Schreiber, G. J., Peterse, J. L., Roberts, C., Marton, M. J., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021967 · Cited by 6,411 · see citing works

Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer

Wang, Y., Klijn, J. G. M., Zhang, Y., Sieuwerts, A. M., Look, M. P., Yang, F., Talantov, D., Timmermans, M. A. M., Gelder, M. E. M., Yu, J. X., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17947-1 · Cited by 2,848 · see citing works

An Immunohistochemical Study

Isaacson, P. G., Doǧan, A., Price, S. K., & Spencer, J. (1989) · The American Journal of Surgical Pathology · doi:10.1097/00000478-198912000-00004 · Cited by 1,913 · see citing works

Metastasis: a question of life or death

Mehlen, P., & Puisieux, A. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1886 · Cited by 1,854 · see citing works

bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes

Sentman, C. L., Shutter, J. R., Hockenbery, D. M., Kanagawa, O., & Korsmeyer, S. J. (1991) · Cell · doi:10.1016/0092-8674(91)90361-2 · Cited by 1,194 · see citing works

NF-κB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression

Huber, M. A., Azoitei, N., Baumann, B., Grünert, S., Sommer, A., Pehamberger, H., Kraut, N., Beug, H., & Wirth, T. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21358 · Cited by 1,035 · see citing works

Constitutive Activation of NF-κB during Progression of Breast Cancer to Hormone-Independent Growth

Nakshatri, H., Bhat‐Nakshatri, P., Martin, D. A., Goulet, R. J., & Sledge, G. W. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.7.3629 · Cited by 818 · see citing works

Expression of relB is required for the development of thymic medulla and dendritic cells

Burkly, L. C., Hession, C. A., Ogata, L., Reilly, C. R., Marconi, L. A., Olson, D. L., Tizard, R., Gate, R., & Lo, D. D. (1995) · Nature · doi:10.1038/373531a0 · Cited by 781 · see citing works

Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer.

Sovak, M. A., Bellas, R. E., Kim, D. W., Zanieski, G., Rogers, A. E., Traish, A. M., & Sonenshein, G. E. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119848 · Cited by 720 · see citing works

Transcriptional regulation of bcl-2 by nuclear factor κB and its significance in prostate cancer

Catz, S. D., & Johnson, J. L. (2001) · Oncogene · doi:10.1038/sj.onc.1204926 · Cited by 538 · see citing works

MTA3, a Mi-2/NuRD Complex Subunit, Regulates an Invasive Growth Pathway in Breast Cancer

Fujita, N., Jaye, D. L., Kajita, M., Geigerman, C., Moreno, C. S., & Wade, P. A. (2003) · Cell · doi:10.1016/s0092-8674(03)00234-4 · Cited by 511 · see citing works

Dissecting p53 tumor suppressor functions in vivo

Schmitt, C. A., Fridman, J. S., Yang, M., Baranov, E., Hoffman, R. M., & Lowe, S. W. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00047-8 · Cited by 481 · see citing works

Transcription factor cross-talk: the estrogen receptor and NF-κB

Kalaitzidis, D., & Gilmore, T. D. (2005) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2005.01.004 · Cited by 388 · see citing works

Changes in estrogen receptor, progesterone receptor, and pS2 expression in tamoxifen-resistant human breast cancer.

Johnston, S. R. D., Saccani‐Jotti, G., Smith, I. E., Salter, J., Newby, J. C., Coppen, M. J., Ebbs, S. R., & Dowsett, M. (1995) · PubMed · Cited by 301 · see citing works

Forkhead Box Transcription Factor FOXO3a Regulates Estrogen Receptor Alpha Expression and Is Repressed by the Her-2/neu/Phosphatidylinositol 3-Kinase/Akt Signaling Pathway

Guo, S., & Sonenshein, G. E. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.19.8681-8690.2004 · Cited by 169 · see citing works

Roles of IKK kinases and protein kinase CK2 in activation of nuclear factor-kappaB in breast cancer.

Romieu, R., Landesman‐Bollag, E., Seldin, D. C., Traish, A. M., Mercurio, F., & Sonenshein, G. E. (2001) · PubMed · Cited by 160 · see citing works

Estradiol increases and anti-estrogens antagonize the growth factor-induced activator protein-1 activity in MCF7 breast cancer cells without affecting c-fos and c-jun synthesis

Philips, A., Chalbos, D., & Rochefort, H. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)85214-6 · Cited by 158 · see citing works

Bcl-2 Activates the Transcription Factor NFκB through the Degradation of the Cytoplasmic Inhibitor IκBα

de Moissac, D., Mustapha, S., Greenberg, A. H., & Kirshenbaum, L. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.37.23946 · Cited by 145 · see citing works

Nuclear localisation of nuclear factor-kappaB transcription factors in prostate cancer: an immunohistochemical study

Lessard, L., Bégin, L. R., Gleave, M. E., Mes‐Masson, A., & Fred Saad, C. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602796 · Cited by 140 · see citing works

Protein kinase CK2 promotes aberrant activation of nuclear factor-kappaB, transformed phenotype, and survival of breast cancer cells.

Romieu, R., Landesman‐Bollag, E., Seldin, D. C., & Sonenshein, G. E. (2002) · PubMed · Cited by 133 · see citing works

Mouse Mammary Tumor Virus c-rel Transgenic Mice Develop Mammary Tumors

Romieu, R., Kim, D. W., Shin, S. M., Demicco, E. G., Landesman‐Bollag, E., Seldin, D. C., Cardiff, R. D., & Sonenshein, G. E. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.16.5738-5754.2003 · Cited by 119 · see citing works

The Tumor Suppressor Activity of the Lysyl Oxidase Propeptide Reverses the Invasive Phenotype of Her-2/neu–Driven Breast Cancer

Min, C., Kirsch, K. H., Zhao, Y., Jeay, S., Palamakumbura, A. H., Trackman, P. C., & Sonenshein, G. E. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3867 · Cited by 110 · see citing works

Nuclear Factor-κB Signature of Inflammatory Breast Cancer by cDNA Microarray Validated by Quantitative Real-time Reverse Transcription-PCR, Immunohistochemistry, and Nuclear Factor-κB DNA-Binding

Laere, S. V., der Auwera, I. V., den Eynden, G. G. V., Elst, H., Weyler, J., Harris, A. L., van Dam, P. A., Marck, E. A. V., Vermeulen, P. B., & Dirix, L. Y. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2800 · Cited by 110 · see citing works

Mechanisms underlying differential expression of interleukin-8 in breast cancer cells

Freund, A., Jolivel, V., Durand, S., Kersual, N., Chalbos, D., Carine Chavey, A., Vignon, F., & Lazennec, G. (2004) · Oncogene · doi:10.1038/sj.onc.1207815 · Cited by 104 · see citing works

Estrogen receptor mediated inhibition of cancer cell invasion and motility: An overview

Rochefort, H., Platet, N., Hayashido, Y., Derocq, D., Lucas, A., Cunat, S., & Garcia, M. (1998) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(98)00010-7 · Cited by 103 · see citing works

RelB regulates manganese superoxide dismutase gene and resistance to ionizing radiation of prostate cancer cells

Josson, S., Xu, Y., Fang, F., Dhar, S. K., Clair, D. K. S., & Clair, W. H. S. (2005) · Oncogene · doi:10.1038/sj.onc.1209186 · Cited by 97 · see citing works

RelB/p52 NF-κB Complexes Rescue an Early Delay in Mammary Gland Development in Transgenic Mice with Targeted Superrepressor IκB-α Expression and Promote Carcinogenesis of the Mammary Gland

Demicco, E. G., Kavanagh, K. T., Romieu, R., Wang, X., Shin, S. R., Landesman‐Bollag, E., Seldin, D. C., & Sonenshein, G. E. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.22.10136-10147.2005 · Cited by 89 · see citing works

FRA-1 Expression Level Modulates Regulation of Activator Protein-1 Activity by Estradiol in Breast Cancer Cells

Philips, A., Teyssier, C., Galtier, F., Rivier-Covas, C., Rey, J.-M., Rochefort, H., & Chalbos, D. (1998) · Molecular Endocrinology · doi:10.1210/mend.12.7.0133 · Cited by 79 · see citing works

Selective inhibition of estrogen-regulated gene expression in vivo by the pure antiestrogen ICI 182,780.

Hyder, S. M., Chiappetta, C., Murthy, L. J., & Stancel, G. M. (1997) · PubMed · Cited by 76 · see citing works

The antiestrogen ICI 182,780 decreases the expression of estrogen receptor-alpha but has no effect on estrogen receptor-beta and androgen receptor in rat efferent ductules

Oliveira, C. A., Nie, R., Carnes, K. I., França, L. R., Prins, G. S., Saunders, P. T. K., & Hess, R. A. (2003) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-1-75 · Cited by 73 · see citing works

Mechanisms of hormone resistance in breast cancer

Horwitz, K. B. (1993) · Breast Cancer Research and Treatment · doi:10.1007/bf00689685 · Cited by 64 · see citing works

7,12-Dimethylbenz(a)Anthracene Treatment of a c-rel Mouse Mammary Tumor Cell Line Induces Epithelial to Mesenchymal Transition via Activation of Nuclear Factor-κB

Shin, S. R., Sánchez-Velar, N., Sherr, D. H., & Sonenshein, G. E. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3056 · Cited by 60 · see citing works

Activation of NF-κB and inhibition of p53-mediated apoptosis by API2/mucosa-associated lymphoid tissue 1 fusions promote oncogenesis

Stoffel, A., Chaurushiya, M. S., Singh, B., & Levine, A. J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402415101 · Cited by 56 · see citing works

Role of the Cyclic AMP Response Element in the bcl-2 Promoter in the Regulation of Endogenous Bcl-2 Expression and Apoptosis in Murine B Cells

Xiang, H., Wang, J., & Boxer, L. M. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.01062-06 · Cited by 54 · see citing works

Induction of the RelB NF-κB Subunit by the Cytomegalovirus IE1 Protein Is Mediated via Jun Kinase and c-Jun/Fra-2 AP-1 Complexes

Wang, X., & Sonenshein, G. E. (2004) · Journal of Virology · doi:10.1128/jvi.79.1.95-105.2005 · Cited by 33 · see citing works

De Novo Synthesized RelB Mediates TNF-Induced Up-Regulation of the Human Polymeric Ig Receptor

Schjerven, H., Tran, T. N., Brandtzæg, P., & Johansen, F. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.3.1849 · Cited by 33 · see citing works

A question of life or death.

Kl, W. (2001) · PubMed · Cited by 14 · see citing works

Chromosomal instability drives metastasis through a cytosolic DNA response

Bakhoum, S. F., Ngo, B., Laughney, A. M., Cavallo, J.-A., Murphy, C. J., Ly, P., Shah, P., Sriram, R. K., Watkins, T. B. K., Taunk, N. K., et al. (2018) · Nature · doi:10.1038/nature25432 · Cited by 1,638 · see citing works

The different roles of ER subtypes in cancer biology and therapy

Thomas, C. G., & Gustafsson, J.-Α. (2011) · Nature reviews. Cancer · doi:10.1038/nrc3093 · Cited by 654 · see citing works

NF-κB and cancer — identifying targets and mechanisms

Naugler, W. E., & Karin, M. (2008) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2008.01.020 · Cited by 636 · see citing works

Sex Differences in Autoimmune Disease from a Pathological Perspective

Fairweather, D., Frisancho-Kiss, S., & Rose, N. R. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.071008 · Cited by 629 · see citing works

Context-Specific Regulation of NF-κB Target Gene Expression by EZH2 in Breast Cancers

Lee, S. T., Li, Z., Wu, Z., Aau, M., Guan, P., Karuturi, R. K. M., Liou, Y. C., & Yu, Q. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.08.011 · Cited by 397 · see citing works

The NF-κB activation pathways, emerging molecular targets for cancer prevention and therapy

Lin, Y., Bai, L., Chen, W., & Xu, S. (2009) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728220903431069 · Cited by 380 · see citing works

NF‐κB and epithelial to mesenchymal transition of cancer

Min, C., Eddy, S. F., Sherr, D. H., & Sonenshein, G. E. (2008) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21695 · Cited by 376 · see citing works

ERβ Impedes Prostate Cancer EMT by Destabilizing HIF-1α and Inhibiting VEGF-Mediated Snail Nuclear Localization: Implications for Gleason Grading

Mak, P., Leav, I., Pursell, B. M., Bae, D., Yang, X., Taglienti, C. A., Gouvin, L. M., Sharma, V. M., & Mercurio, A. M. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.02.030 · Cited by 373 · see citing works

Inflammation: A driving force speeds cancer metastasis

Wu, Y., & Zhou, B. P. (2009) · Cell Cycle · doi:10.4161/cc.8.20.9699 · Cited by 327 · see citing works

Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers

Sabbah, M., Emami, S., Redeuilh, G., Julien-Grille, S., Prevost, G. P., Zimber, A., Ouelaa-Benslama, R., Bracke, M., Wever, O. D., & Gespach, C. P. (2008) · Drug Resistance Updates · doi:10.1016/j.drup.2008.07.001 · Cited by 322 · see citing works

Estrogen and Cancer

Liang, J., & Shang, Y. (2012) · Annual Review of Physiology · doi:10.1146/annurev-physiol-030212-183708 · Cited by 319 · see citing works

Role of NF-κB in the skeleton

Novack, D. V. (2010) · Cell Research · doi:10.1038/cr.2010.159 · Cited by 319 · see citing works

Cancer metastasis: Mechanisms of inhibition by melatonin

Su, S., Hsieh, M., Yang, W., Chung, W., Reiter, R. J., & Yang, S. (2016) · Journal of Pineal Research · doi:10.1111/jpi.12370 · Cited by 285 · see citing works

Targeting the NFκB Signaling Pathways for Breast Cancer Prevention and Therapy

Wang, W., Nag, S. A., & Zhang, R. (2014) · Current Medicinal Chemistry · doi:10.2174/0929867321666141106124315 · Cited by 280 · see citing works

MicroRNA-520/373 family functions as a tumor suppressor in estrogen receptor negative breast cancer by targeting NF-κB and TGF-β signaling pathways

Keklikoglou, I., Körner, C., Schmidt, C., Zhang, J. D., Heckmann, D., Shavinskaya, A., Allgayer, H., Gückel, B., Fehm, T. N., Schneeweiß, A., et al. (2011) · Oncogene · doi:10.1038/onc.2011.571 · Cited by 273 · see citing works

Non-canonical NF-κB Antagonizes STING Sensor-Mediated DNA Sensing in Radiotherapy

Hou, Y., Liang, H. L., Rao, E., Zheng, W., Huang, X., Deng, L., Zhang, Y., Yu, X., Xu, M. M., Mauceri, H. J., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.07.008 · Cited by 270 · see citing works

Regulation of gene expression by hypoxia

Kenneth, N. S., & Rocha, S. (2008) · Biochemical Journal · doi:10.1042/bj20081055 · Cited by 264 · see citing works

The NF-κB Pathway and Cancer Stem Cells

Rinkenbaugh, A. L., & Baldwin, A. S. (2016) · Cells · doi:10.3390/cells5020016 · Cited by 265 · see citing works

The immune system and inflammation in breast cancer

Jiang, X., & Shapiro, D. J. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.06.003 · Cited by 243 · see citing works

NF-κB Signaling Pathway and Its Therapeutic Implications in Human Diseases

Sarkar, F. H., Li, Y., Wang, Z. P., & Kong, D. (2008) · International Reviews of Immunology · doi:10.1080/08830180802276179 · Cited by 227 · see citing works

Curcumin reduces the expression of Bcl-2 by upregulating miR-15a and miR-16 in MCF-7 cells

Yang, J., Cao, Y., Sun, J., & Zhang, Y. (2009) · Medical Oncology · doi:10.1007/s12032-009-9344-3 · Cited by 219 · see citing works

New insights of epithelial-mesenchymal transition in cancer metastasis

Wu, Y., & Zhou, B. P. (2008) · Acta Biochimica et Biophysica Sinica · doi:10.1111/j.1745-7270.2008.00443.x · Cited by 218 · see citing works

Subcellular Localization and Dynamics of the Bcl-2 Family of Proteins

Popgeorgiev, N., Jabbour, L., & Gillet, G. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00013 · Cited by 197 · see citing works

A new cross-talk between the aryl hydrocarbon receptor and RelB, a member of the NF-κB family

Vogel, C. F. A., & Matsumura, F. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.09.036 · Cited by 196 · see citing works

NF-κB, stem cells and breast cancer: the links get stronger

Shostak, K., & Chariot, A. (2011) · Breast Cancer Research · doi:10.1186/bcr2886 · Cited by 180 · see citing works

Chemokines: novel targets for breast cancer metastasis

Ali, S., & Lazennec, G. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9073-z · Cited by 178 · see citing works

The Human Cytomegalovirus Protein TRS1 Inhibits Autophagy via Its Interaction with Beclin 1

Chaumorcel, M., Lussignol, M., Mouna, L., Cavignac, Y., Fahie, K., Cotte-Laffitte, J., Geballe, A. P., Brune, W., Beau, I., Codogno, P., et al. (2011) · Journal of Virology · doi:10.1128/jvi.05746-11 · Cited by 175 · see citing works

Minireview: Inflammation: An Instigator of More Aggressive Estrogen Receptor (ER) Positive Breast Cancers

Baumgarten, S. C., & Frasor, J. M. (2012) · Molecular Endocrinology · doi:10.1210/me.2011-1302 · Cited by 173 · see citing works

Hyperactivated NF-κB and AP-1 Transcription Factors Promote Highly Accessible Chromatin and Constitutive Transcription across the Interleukin-6 Gene Promoter in Metastatic Breast Cancer Cells

Ndlovu, M. N., Lint, C. M. V., Wesemael, K. V., Callebert, P., Chalbos, D., Haegeman, G., & Berghe, W. V. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01657-08 · Cited by 156 · see citing works

Platelet-Derived Growth Factor-D Overexpression Contributes to Epithelial-Mesenchymal Transition of PC3 Prostate Cancer Cells

Kong, D., Wang, Z., Sarkar, S. H., Li, Y., Banerjee, S., Saliganan, A. D., Kim, H.-R. C., Cher, M. L., & Sarkar, F. H. (2008) · Stem Cells · doi:10.1634/stemcells.2007-1076 · Cited by 155 · see citing works

Plumbagin‐induced apoptosis of human breast cancer cells is mediated by inactivation of NF‐κB and Bcl‐2

Ahmad, A., Banerjee, S., Wang, Z. P., Kong, D., & Sarkar, F. H. (2008) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21966 · Cited by 151 · see citing works

Positive Cross-Talk between Estrogen Receptor and NF-κB in Breast Cancer

Frasor, J. M., Weaver, A., Pradhan, M., Dai, Y., Miller, L. D., Lin, C., & Stanculescu, A. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-2608 · Cited by 148 · see citing works

Gonadectomy of male BALB/c mice increases Tim-3+ alternatively activated M2 macrophages, Tim-3+ T cells, Th2 cells and Treg in the heart during acute coxsackievirus-induced myocarditis

Frisancho-Kiss, S., Coronado, M. J., Frisancho, J. A., Lau, V. M., Rose, N. R., Klein, S. L., & Fairweather, D. (2009) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2008.12.002 · Cited by 143 · see citing works

miR-218 inhibits the invasive ability of glioma cells by direct downregulation of IKK-β

Song, L., Huang, Q., Chen, K., Liu, L., Lin, C., Dai, T., Yu, C., Wu, Z., & Li, J. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.10.003 · Cited by 136 · see citing works

Thioredoxin-like 2 regulates human cancer cell growth and metastasis via redox homeostasis and NF-κB signaling

Qu, Y., Wang, J., Ray, P., Guo, H. B., Huang, J., Shin-Sim, M., Bukoye, B. A., Liu, B., Lee, A. V., Lin, X., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci43144 · Cited by 126 · see citing works

Biochemistry, Cell Biology, and Pathophysiology of the Innate Immune cGAS–cGAMP–STING Pathway

Ritchie, C., Carozza, J. A., & Li, L. (2022) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-040320-101629 · Cited by 121 · see citing works

IKKα controls canonical TGFβ–SMAD signaling to regulate genes expressing SNAIL and SLUG during EMT in Panc1 cells

Brandl, M., Seidler, B., Haller, F., Adamski, J., Schmid, R. M., Saur, D., & Schneider, G. (2010) · Journal of Cell Science · doi:10.1242/jcs.071100 · Cited by 119 · see citing works

Non-apoptotic roles of Bcl-2 family: The calcium connection

Bonneau, B., Prudent, J., Popgeorgiev, N., & Gillet, G. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.01.021 · Cited by 119 · see citing works

ERα, microRNAs, and the epithelial–mesenchymal transition in breast cancer

Reed, I. K. G., Adams, B. D., & White, B. A. (2012) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2011.12.001 · Cited by 112 · see citing works

Over‐expression of AEG‐1 significantly associates with tumour aggressiveness and poor prognosis in human non‐small cell lung cancer

Song, L., Li, W., Zhang, H., Liao, W., Dai, T., Yu, C., Ding, X., Zhang, L., & Li, J. (2009) · The Journal of Pathology · doi:10.1002/path.2595 · Cited by 112 · see citing works

ADAM8 expression in invasive breast cancer promotes tumor dissemination and metastasis

Romagnoli, M., Mineva, N. D., Polmear, M. M., Conrad, C., Srinivasan, S. S., Loussouarn, D., Barillé‐Nion, S., Georgakoudi, I., Dagg, Á., McDermott, E. W. M., et al. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201303373 · Cited by 110 · see citing works

Complete reversal of epithelial to mesenchymal transition requires inhibition of both ZEB expression and the Rho pathway

Das, S., Becker, B. N., Hoffmann, F. M., & Mertz, J. E. (2009) · BMC Cell Biology · doi:10.1186/1471-2121-10-94 · Cited by 109 · see citing works

Bcl-2 Family of Proteins in the Control of Mitochondrial Calcium Signalling: An Old Chap with New Roles

Morris, J. L., Gillet, G., Prudent, J., & Popgeorgiev, N. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073730 · Cited by 108 · see citing works

Epigallocatechin-3-Gallate Inhibits Stem-Like Inflammatory Breast Cancer Cells

Mineva, N. D., Paulson, K. E., Naber, S. P., Yee, A. S., & Sonenshein, G. E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073464 · Cited by 103 · see citing works

Identification of Functional Networks of Estrogen- and c-Myc-Responsive Genes and Their Relationship to Response to Tamoxifen Therapy in Breast Cancer

Musgrove, E. A., Sergio, C. M., Loi, S., Inman, C. K., Anderson, L. R., Alles, M. C., Pinese, M., Caldon, C. E., Schütte, J., Gardiner‐Garden, M., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002987 · Cited by 99 · see citing works

The interaction between ER and NFκB in resistance to endocrine therapy

Sas, L., Lardon, F., Vermeulen, P. B., Hauspy, J., van Dam, P. A., Pauwels, P., Dirix, L. Y., & Laere, S. V. (2012) · Breast Cancer Research · doi:10.1186/bcr3196 · Cited by 100 · see citing works

Inflammation Fuels Tumor Progress and Metastasis

Liu, J., Lin, P. C., & Zhou, B. P. (2015) · Current Pharmaceutical Design · doi:10.2174/1381612821666150514105741 · Cited by 99 · see citing works

Nuclear factor-κB signaling and ezrin are essential for L1-mediated metastasis of colon cancer cells

Gavert, N. S., Ben‐Shmuel, A., Lemmon, V., Brabletz, T., & Ben‐Ze'ev, A. (2010) · Journal of Cell Science · doi:10.1242/jcs.069542 · Cited by 98 · see citing works

Apoptosis‐inducing effect of garcinol is mediated by NF‐κB signaling in breast cancer cells

Ahmad, A., Wang, Z. P., Raza, A., Maitah, M. Y., Kong, D., Banerjee, S., Padhyé, S., & Sarkar, F. H. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22492 · Cited by 96 · see citing works

Epithelial-to-Mesenchymal Transition Induced by TGF-β1 Is Mediated by Blimp-1–Dependent Repression of BMP-5

Romagnoli, M., Belguise, K., Yu, Z., Wang, X., Landesman‐Bollag, E., Seldin, D. C., Chalbos, D., Barillé‐Nion, S., Jézéquel, P., Seldin, M. L., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-2270 · Cited by 95 · see citing works

Epithelial-mesenchymal Transition and Its Role in the Pathogenesis of Colorectal Cancer

Zhu, Q., Gao, R., Wu, W., & Qin, H. (2013) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2013.14.5.2689 · Cited by 94 · see citing works

Epithelial-Mesenchymal Transition (EMT) and Regulation of EMT Factors by Steroid Nuclear Receptors in Breast Cancer: A Review and in Silico Investigation

Voutsadakis, I. A. (2016) · Journal of Clinical Medicine · doi:10.3390/jcm5010011 · Cited by 94 · see citing works

Emerging roles of PDGF-D in EMT progression during tumorigenesis

Wu, Q., Hou, X., Xia, J., Qian, X., Miele, L., Sarkar, F. H., & Wang, Z. P. (2012) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2012.11.006 · Cited by 91 · see citing works

Analysis of the TGFβ-induced program in primary airway epithelial cells shows essential role of NF-κB/RelA signaling network in type II epithelial mesenchymal transition

Tian, B., Li, X., Kalita, M. K., Widen, S. G., Yang, J., Bhavnani, S. K., Dang, B., Kudlicki, A. S., Sinha, M., Kong, F., et al. (2015) · BMC Genomics · doi:10.1186/s12864-015-1707-x · Cited by 89 · see citing works

Cancer Stem Cell-Like Phenotype and Survival Are Coordinately Regulated by Akt/FoxO/Bim Pathway

Gargini, R., Cerliani, J. P., Escoll, M., Anton, I. M., & Wandosell, F. G. (2014) · Stem Cells · doi:10.1002/stem.1904 · Cited by 85 · see citing works

The NF-κB Activating Pathways in Multiple Myeloma

Roy, P., Sarkar, U. A., & Basak, S. (2018) · Biomedicines · doi:10.3390/biomedicines6020059 · Cited by 85 · see citing works

BRCA1 And Estrogen/Estrogen Receptor In Breast Cancer: Where They Interact?

Wang, L., & Di, L. (2014) · International Journal of Biological Sciences · doi:10.7150/ijbs.8579 · Cited by 82 · see citing works

ERβ1 represses basal-like breast cancer epithelial to mesenchymal transition by destabilizing EGFR

Thomas, C. G., Rajapaksa, G. K., Nikolos, F., Hao, R., Katchy, A., McCollum, C. W., Bondesson, M., Quinlan, P., Thompson, A. M., Krishnamurthy, S., et al. (2012) · Breast Cancer Research · doi:10.1186/bcr3358 · Cited by 80 · see citing works

The canonical NF-κB pathway is required for formation of luminal mammary neoplasias and is activated in the mammary progenitor population

Pratt, M. A. C., Tibbo, E., Robertson, S., Jansson, D., Hurst, K., Perez‐Iratxeta, C., Lau, R., & Niu, M. Y. (2009) · Oncogene · doi:10.1038/onc.2009.131 · Cited by 79 · see citing works

Melatonin as a promising agent to treat ovarian cancer: molecular mechanisms

Chuffa, L. G. D. A., Reiter, R. J., & Lupi, L. A. (2017) · Carcinogenesis · doi:10.1093/carcin/bgx054 · Cited by 79 · see citing works

Consequences of EMT-Driven Changes in the Immune Microenvironment of Breast Cancer and Therapeutic Response of Cancer Cells

Singh, S., & Chakrabarti, R. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8050642 · Cited by 78 · see citing works

Recent insights into the molecular mechanisms involved in aging and the malignant transformation of adult stem/progenitor cells and their therapeutic implications

Mimeault, M., & Batra, S. (2008) · Ageing Research Reviews · doi:10.1016/j.arr.2008.12.001 · Cited by 76 · see citing works

The PKCθ pathway participates in the aberrant accumulation of Fra-1 protein in invasive ER-negative breast cancer cells

Belguise, K., Milord, S., Galtier, F., Moquet-Torcy, G., Piechaczyk, M., & Chalbos, D. (2012) · Oncogene · doi:10.1038/onc.2011.659 · Cited by 76 · see citing works

Estrogen Reduces Aldosterone, Upregulates Adrenal Angiotensin II AT<sub>2</sub> Receptors and Normalizes Adrenomedullary Fra-2 in Ovariectomized Rats

Macova, M., Armando, I., Zhou, J., Baiardi, G., Tyurmin, D., Larrayoz-Roldan, I. M., & Saavedra, J. M. (2008) · Neuroendocrinology · doi:10.1159/000150977 · Cited by 75 · see citing works

Bone morphogenetic protein 7 induces mesenchymal‐to‐epithelial transition in melanoma cells, leading to inhibition of metastasis

Na, Y., Seok, S. H., Kim, D., Han, J., Kim, T., Jung, H. J., Lee, B., & Park, J. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01301.x · Cited by 75 · see citing works

Loss of ERα induces amoeboid-like migration of breast cancer cells by downregulating vinculin

Gao, Y., Wang, Z., Hao, Q., Li, W., Xu, Y., Zhang, J., Zhang, W., Wang, S., Liu, S., Li, M., et al. (2017) · Nature Communications · doi:10.1038/ncomms14483 · Cited by 75 · see citing works

Bcl-2 Overexpression Induces a Partial Epithelial to Mesenchymal Transition and Promotes Squamous Carcinoma Cell Invasion and Metastasis

Zuo, J., Ishikawa, T., Boutros, S., Xiao, Z., Humtsoe, J. O., & Kramer, R. H. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0354 · Cited by 74 · see citing works

RelB NF-κB Represses Estrogen Receptor α Expression via Induction of the Zinc Finger Protein Blimp1

Wang, X., Belguise, K., O’Neill, C. F., Sánchez-Morgan, N., Romagnoli, M., Eddy, S. F., Mineva, N. D., Yu, Z., Min, C., Trinkaus‐Randall, V., et al. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00032-09 · Cited by 72 · see citing works

PKCθ promotes c-Rel–driven mammary tumorigenesis in mice and humans by repressing estrogen receptor α synthesis

Belguise, K., & Sonenshein, G. E. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32424 · Cited by 71 · see citing works

NF-κB, Mesenchymal Differentiation and Glioblastoma

Yamini, B. (2018) · Cells · doi:10.3390/cells7090125 · Cited by 69 · see citing works

Interaction of aryl hydrocarbon receptor and NF-κB subunit RelB in breast cancer is associated with interleukin-8 overexpression

Vogel, C. F. A., Li, W., Wu, D., Miller, J. K., Sweeney, C. A., Lazennec, G., Fujisawa, Y., & Matsumura, F. (2011) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2011.05.011 · Cited by 68 · see citing works

The NF-κB RelB Protein Is an Oncogenic Driver of Mesenchymal Glioma

Lee, D. W., Ramakrishnan, D., Valenta, J., Parney, I. F., Bayless, K. J., & Sitcheran, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057489 · Cited by 68 · see citing works

The adhesion G protein-coupled receptor G2 (ADGRG2/GPR64) constitutively activates SRE and NFκB and is involved in cell adhesion and migration

Peeters, M. C., Fokkelman, M., Boogaard, B., Egerod, K. L., van de Water, B., IJzerman, A. P., & Schwartz, T. W. (2015) · Cellular Signalling · doi:10.1016/j.cellsig.2015.08.015 · Cited by 67 · see citing works

A Loss-of-Function Polymorphism in the Propeptide Domain of the LOX Gene and Breast Cancer

Min, C., Yu, Z., Kirsch, K. H., Zhao, Y., Vora, S. R., Trackman, P. C., Spicer, D. B., Rosenberg, L. A., Palmer, J. R., & Sonenshein, G. E. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4818 · Cited by 67 · see citing works

The Apoptotic Regulator Nrz Controls Cytoskeletal Dynamics via the Regulation of Ca2+ Trafficking in the Zebrafish Blastula

Popgeorgiev, N., Bonneau, B., Ferri, K. F., Prudent, J., Thibaut, J., & Gillet, G. (2011) · Developmental Cell · doi:10.1016/j.devcel.2011.03.016 · Cited by 66 · see citing works

Withanolides-Induced Breast Cancer Cell Death Is Correlated with Their Ability to Inhibit Heat Protein 90

Wang, H., Tsai, Y.-L., Wu, Y., Chang, F., Liu, M.-H., Chen, W.-Y., & Wu, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037764 · Cited by 66 · see citing works

Molecular Markers of Epithelial-to-Mesenchymal Transition Are Associated with Tumor Aggressiveness in Breast Carcinoma

Sethi, S. N., Sarkar, F. H., Ahmed, Q. F., Bandyopadhyay, S., Nahleh, Z. A., Semaan, A. Y., Sakr, W., Munkarah, A. R., & Ali‐Fehmi, R. (2011) · Translational Oncology · doi:10.1593/tlo.10244 · Cited by 66 · see citing works

Diallyl Disulfide-Induced Apoptosis in a Breast-Cancer Cell Line (MCF-7) May Be Caused by Inhibition of Histone Deacetylation

Altonsy, M. O., Habib, T. N., & Andrews, S. C. (2012) · Nutrition and Cancer · doi:10.1080/01635581.2012.721156 · Cited by 66 · see citing works

Noncanonical NF-κB in Cancer

Tegowski, M., & Baldwin, A. S. (2018) · Biomedicines · doi:10.3390/biomedicines6020066 · Cited by 67 · see citing works

The Lysyl Oxidase Pro-peptide Attenuates Fibronectin-mediated Activation of Focal Adhesion Kinase and p130Cas in Breast Cancer Cells

Zhao, Y., Min, C., Vora, S. R., Trackman, P. C., Sonenshein, G. E., & Kirsch, K. H. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802612200 · Cited by 65 · see citing works

The Emerging Function of PKCtheta in Cancer

Nicolle, A., Zhang, Y., & Belguise, K. (2021) · Biomolecules · doi:10.3390/biom11020221 · Cited by 64 · see citing works

Altered gene products involved in the malignant reprogramming of cancer stem/progenitor cells and multitargeted therapies

Mimeault, M., & Batra, S. K. (2013) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2013.08.001 · Cited by 63 · see citing works

Gain of Oncogenic Function of p53 Mutants Induces Invasive Phenotypes in Human Breast Cancer Cells by Silencing CCN5/WISP-2

Dhar, G., Banerjee, S., Dhar, K., Tawfik, O. W., Mayo, M. S., VanVeldhuizen, P. J., & Banerjee, S. K. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0316 · Cited by 62 · see citing works

Estrogen Receptors in Epithelial-Mesenchymal Transition of Prostate Cancer

Zazzo, E. D., Galasso, G., Giovannelli, P., Donato, M. D., Bilancio, A., Perillo, B., Sinisi, A. A., Migliaccio, A., & Castoria, G. (2019) · Cancers · doi:10.3390/cancers11101418 · Cited by 62 · see citing works

NFκB affects estrogen receptor expression and activity in breast cancer through multiple mechanisms

Frasor, J. M., El-Shennawy, L., Stender, J. D., & Kastrati, I. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.09.013 · Cited by 61 · see citing works

Notch3 Maintains Luminal Phenotype and Suppresses Tumorigenesis and Metastasis of Breast Cancer via Trans-Activating Estrogen Receptor-α

Dou, X., Liang, Y., Lin, H., Wei, X., Zhang, Y., Bai, J., Chen, C., Chen, M., Du, C., Li, Y., et al. (2017) · Theranostics · doi:10.7150/thno.19989 · Cited by 61 · see citing works

Natural and Synthetic Estrogens in Chronic Inflammation and Breast Cancer

Maharjan, C. K., Mo, J., Wang, L. A., Kim, M., Wang, S., Borcherding, N. C., Vikas, P., & Zhang, W. (2021) · Cancers · doi:10.3390/cancers14010206 · Cited by 62 · see citing works

Targeting Cellular Signaling Pathways in Breast Cancer Stem Cells and its Implication for Cancer Treatment

Pires, B. R. B., de Amorim, Í. S. S., Souza, L. D. E., Rodrigues, J. A., & Mencalha, A. L. (2016) · Anticancer Research · doi:10.21873/anticanres.11151 · Cited by 59 · see citing works

Down-regulation of Forkhead box protein A1 (FOXA1) leads to cancer stem cell-like properties in tamoxifen-resistant breast cancer cells through induction of interleukin-6

Yamaguchi, N., Nakayama, Y., & Yamaguchi, N. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.763276 · Cited by 58 · see citing works

RelB: an outlier in leukocyte biology

Millet, P., McCall, C. E., & Yoza, B. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.0513305 · Cited by 57 · see citing works

Hypercapnia Induces Cleavage and Nuclear Localization of RelB Protein, Giving Insight into CO2 Sensing and Signaling

Oliver, K. M., Lenihan, C. R., Brüning, U., Cheong, A., Laffey, J. G., McLoughlin, P., Taylor, C. T., & Cummins, E. P. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.347971 · Cited by 55 · see citing works

Modulation of oncogenic transcription factors by bioactive natural products in breast cancer

Hasanpourghadi, M., Pandurangan, A. K., & Mustafa, M. R. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.09.009 · Cited by 55 · see citing works

LncRNA DGCR5 plays a tumor-suppressive role in glioma via the miR-21/Smad7 and miR-23a/PTEN axes

He, Z., Long, J., Yang, C., Gong, B., Cheng, M., Wang, Q., & Tang, J. X. (2020) · Aging · doi:10.18632/aging.103800 · Cited by 54 · see citing works

TOM1L1 drives membrane delivery of MT1-MMP to promote ERBB2-induced breast cancer cell invasion

Chevalier, C., Collin, G., Descamps, S., Touaitahuata, H., Simon, V., Reymond, N., Fernandez, L., Milhiet, P., Georget, V., Urbach, S., et al. (2016) · Nature Communications · doi:10.1038/ncomms10765 · Cited by 53 · see citing works

NFκB signaling is important for growth of antiestrogen resistant breast cancer cells

Yde, C. W., Emdal, K. B., Guerra, B., & Lykkesfeldt, A. E. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2053-1 · Cited by 51 · see citing works

Post-Translational Modifications of RelB NF-κB Subunit and Associated Functions

Baud, V., & Collares, D. (2016) · Cells · doi:10.3390/cells5020022 · Cited by 49 · see citing works

New advances on critical implications of tumor- and metastasis-initiating cells in cancer progression, treatment resistance and disease recurrence.

Mimeault, M., & Batra, S. K. (2010) · PubMed · doi:10.14670/hh-25.1057 · Cited by 48 · see citing works

Disruptive environmental chemicals and cellular mechanisms that confer resistance to cell death

Narayanan, K. B., Ali, M., Barclay, B. J., Cheng, Q. S., D'Abronzo, L. S., Dornetshuber-Fleiss, R., Ghosh, P., Guzman, M. J. G., Lee, T. J., Leung, P. S., et al. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv032 · Cited by 47 · see citing works

CD40 Ligand-mediated Activation of the de Novo RelB NF-κB Synthesis Pathway in Transformed B Cells Promotes Rescue from Apoptosis

Mineva, N. D., Rothstein, T. L., Meyers, J. A., Lerner, A., & Sonenshein, G. E. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m607313200 · Cited by 46 · see citing works

RelB NF-κB Represses Estrogen Receptor α Expression via Induction of the Zinc Finger Protein Blimp1

Wang, X., Belguise, K., O’Neill, C. F., Sánchez-Morgan, N., Romagnoli, M., Eddy, S. F., Mineva, N. D., Yu, Z., Min, C., Trinkaus‐Randall, V., et al. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00032-09 · Cited by 72 · see citing works

Abstract P4-06-14: Induction of Blimp-1 in Breast Cancer Cells Is Mediated by Activator Protein-1 and Promotes Transforming Growth Factor (TGF)-ß-Induced Epithelial-to-Mesenchymal Transition

Romagnoli, M., Belguise, K., Wang, X., & Sonenshein, G. (2010) · Cancer Research · doi:10.1158/0008-5472.sabcs10-p4-06-14

Tumour necrosis factor and PI3-kinase control oestrogen receptor alpha protein level and its transrepression function

Bhat‐Nakshatri, P., Campbell, R. A., Patel, N. M., Newton, T. R., King, A. J., Marshall, M. S., Ali, S., & Nakshatri, H. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601541 · Cited by 30 · see citing works

NF-κB links oestrogen receptor signalling and EMT

Radisky, D. C., & Bissell, M. J. (2007) · Nature Cell Biology · doi:10.1038/ncb0407-361 · Cited by 41 · see citing works

NF‐κB and estrogen receptor α interactions: Differential function in estrogen receptor‐negative and ‐positive hormone‐independent breast cancer cells

Gionet, N., Jansson, D., Mader, S., & Pratt, M. A. C. (2009) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22141 · Cited by 46 · see citing works